13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand E7-D10/3

2023 Edition

ANYGENES

fr

AnyGenes® is a R&D biotechnology, totally owned by its founders.
Based on more than 15 years of experience, AnyGenes has three main activities: i) produces, manufactures and markets innovative and focused panel assays of signaling pathways, epigenetic (methylation analysis), microbiome and biomarkers profiling for translational medicine, ii) services for drug development by using our proprietary molecular platform, iii) development of multi-biomarkers clinical tests

Scroll to Top
  • No products in the cart.